NSCLC patients with oligo-metastatic brain disease show an altered CD4 T-cells immune profile
Mais Alsousli, Cécile L. Maire, András Piffkó, Jakob Matschke, Laura Glau, Merle Reetz, Svenja Schneegans, Gresa Emurlai, Benedikt Asey, Alessandra Rünger, Sven Peine, Jolanthe Kropidlowski, Jens Gempt, Markus Glatzel, Manfred Westphal, , Harriet Wikman
The paper identifies altered CD4 T-cell immune profiles in NSCLC patients with oligo-metastatic brain disease compared to poly-metastatic disease and healthy controls.
Acta Neuropathologica Communications · May 9, 2025Peer-reviewedCancer Biology